Cowen & Co. Initiates Coverage On Biodesix with Outperform Rating
Cowen & Co. analyst Max Masucci initiates coverage on Biodesix (NASDAQ:BDSX) with a Outperform rating.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers
Zosano Pharma (NASDAQ:ZSAN) shares rose 3127.9% to $3.88 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.0 million.
A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report
Pre-open movers
U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation number for March, which is forecasted at 8.4%, a steep rise from 7.9% in February.
Why This Nano-Cap Healthcare Stock Spiked Over 80% After-Hours Today
Shares of Biodesix, Inc. (NASDAQ: BDSX), a lung disease-focused diagnostics company, skyrocketed in after-hours trading on Monday.
Biodesix Highlights Publication Of Data In ‘Diagnostics’ Validating Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer
Additionally, data associated with the GeneStrat® ddPCR™ and Genestrat NGS™ blood tests will be presented at the American Association for Cancer Research (AACR)
BOULDER, Colo.--(BUSINESS WIRE)--
Biodesix Q4 EPS $(0.49), Inline, Sales $7.22M Miss $7.30M Estimate
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.49) per share which met the analyst consensus estimate. This is a 96 percent decrease over losses of $(0.25) per share from the same period last year. The company